Source link : https://newshealth.biz/health-news/early-ctdna-changes-predict-immunotherapy-outcomes-in-crc/
TOPLINE: In patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (CRC) who received immune checkpoint inhibitors, changes in circulating tumor DNA (ctDNA) concentrations at 1-month post-treatment predicted progression-free survival (PFS) and overall survival. Favorable ctDNA responders experienced significantly improved survival with the immune checkpoint inhibitor avelumab than with chemotherapy. METHODOLOGY: Immune checkpoint inhibitors […]
The post Early ctDNA Changes Predict Immunotherapy Outcomes in CRC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-18 06:56:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8